Meda AB Acquires OTC Products in the US

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regualtory News: Meda has acquired three well established Over-The-Counter consumer products in the US from GlaxoSmithKline LLC (“GSK”). Total annual sales for the products are about 100 MSEK, with strong profit margins. The purchase price was 235 MSEK.
MORE ON THIS TOPIC